150 related articles for article (PubMed ID: 24692395)
1. Implementation of the bethesda system for reporting thyroid cytopathology: interobserver concordance and reclassification of previously inconclusive aspirates.
Pathak P; Srivastava R; Singh N; Arora VK; Bhatia A
Diagn Cytopathol; 2014 Nov; 42(11):944-9. PubMed ID: 24692395
[TBL] [Abstract][Full Text] [Related]
2. A tertiary center's experience with second review of 3885 thyroid cytopathology specimens.
Olson MT; Boonyaarunnate T; Aragon Han P; Umbricht CB; Ali SZ; Zeiger MA
J Clin Endocrinol Metab; 2013 Apr; 98(4):1450-7. PubMed ID: 23436916
[TBL] [Abstract][Full Text] [Related]
3. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
[TBL] [Abstract][Full Text] [Related]
4. Reclassifying formerly indeterminate thyroid FNAs using the Bethesda system reduces the number of inconclusive cases.
Song JY; Chu YC; Kim L; Park IS; Han JY; Kim JM
Acta Cytol; 2012; 56(2):122-9. PubMed ID: 22378073
[TBL] [Abstract][Full Text] [Related]
5. Application of the Bethesda System for Reporting Thyroid Cytopathology in the Eastern Province of Saudi Arabia: phase I pilot retrospective analysis.
Al-Abbadi MA; Shareef SQ; Ali JA; Yousef MM
Acta Cytol; 2013; 57(5):481-8. PubMed ID: 24021940
[TBL] [Abstract][Full Text] [Related]
6. Thyroid fine-needle aspiration reporting rates and outcomes before and after Bethesda implementation within a combined academic and community hospital system.
Harvey AM; Mody DR; Amrikachi M
Arch Pathol Lab Med; 2013 Nov; 137(11):1664-8. PubMed ID: 24168507
[TBL] [Abstract][Full Text] [Related]
7. Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for Reporting Thyroid Cytopathology.
Chen JC; Pace SC; Chen BA; Khiyami A; McHenry CR
Surgery; 2012 Dec; 152(6):1037-44. PubMed ID: 23040711
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
Wong LQ; Baloch ZW
Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
[TBL] [Abstract][Full Text] [Related]
9. Application of the Bethesda Classification for Thyroid Fine-Needle Aspiration: Institutional Experience and Meta-analysis.
Krauss EA; Mahon M; Fede JM; Zhang L
Arch Pathol Lab Med; 2016 Oct; 140(10):1121-31. PubMed ID: 27684984
[TBL] [Abstract][Full Text] [Related]
10. Thyroid fine-needle aspiration cytology: is there a place to virtual cytology?
Gerhard R; Teixeira S; Gaspar da Rocha A; Schmitt F
Diagn Cytopathol; 2013 Sep; 41(9):793-8. PubMed ID: 23441010
[TBL] [Abstract][Full Text] [Related]
11. The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the surgical treatment of thyroid nodules.
Richmond BK; O'Brien BA; Mangano W; Thompson S; Kemper S
Am Surg; 2012 Jun; 78(6):706-10. PubMed ID: 22643269
[TBL] [Abstract][Full Text] [Related]
12. Consistency in the Distribution of Bethesda System for Reporting Thyroid Cytology Categories Over 9 Years: A Single Institute, Retrospective Study.
Harris M; Zloczower E; Pinhas S; Allon R; Zornitzki T; Malka L; Cohen Y; Lahav Y; Cohen O
Endocr Pract; 2024 Jun; 30(6):546-550. PubMed ID: 38570016
[TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration cytology of nodular thyroid lesions: a 2-year experience of the Bethesda system for reporting thyroid cytopathology in a large regional and a university hospital, with histological correlation.
Mastorakis E; Meristoudis C; Margari N; Pouliakis A; Leventakos K; Chroniaris N; Panayiotides I; Karakitsos P
Cytopathology; 2014 Apr; 25(2):120-8. PubMed ID: 23551656
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of the Bethesda system for reporting thyroid cytopathology: Real-life experience.
Avior G; Dagan O; Shochat I; Frenkel Y; Tessler I; Meir A; Jaffe A; Cohen O
Clin Endocrinol (Oxf); 2021 Mar; 94(3):521-527. PubMed ID: 32981060
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of Bethesda system for reporting thyroid cytopathology: an institutional perspective.
Naz S; Hashmi AA; Khurshid A; Faridi N; Edhi MM; Kamal A; Khan M
Int Arch Med; 2014; 7():46. PubMed ID: 25945126
[TBL] [Abstract][Full Text] [Related]
16. Application of the Bethesda System for Reporting Thyroid Cytopathology in the Eastern Province of Saudi Arabia: A Follow-Up Study.
Alabdulqader NA; Shareef SQ; Ali JA; Yousef MM; Al-Abbadi MA
Acta Cytol; 2015; 59(3):233-8. PubMed ID: 26044567
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Bethesda System for Reporting Thyroid Cytopathology in a Danish tertiary centre.
Madsen SH; Jespersen ML; Bonnema SJ; Rolighed L; Swan KZ
Dan Med J; 2024 May; 71(6):. PubMed ID: 38847411
[TBL] [Abstract][Full Text] [Related]
18. The interobserver reproducibility of thyroid cytopathology using Bethesda Reporting System: analysis of 200 cases.
Ahmed S; Ahmad M; Khan MA; Kazi F; Noreen F; Nawaz S; Sohail I
J Pak Med Assoc; 2013 Oct; 63(10):1252-5. PubMed ID: 24392554
[TBL] [Abstract][Full Text] [Related]
19. Variability in the atypia of undetermined significance/follicular lesion of undetermined significance diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: sources and recommendations.
Ohori NP; Schoedel KE
Acta Cytol; 2011; 55(6):492-8. PubMed ID: 22156456
[TBL] [Abstract][Full Text] [Related]
20. The Bethesda System for Reporting Thyroid Cytopathology is applicable to frozen section diagnosis in children.
Arnold MA; Nicol KK
Pediatr Dev Pathol; 2015; 18(2):139-45. PubMed ID: 25625563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
